|
 |
Increase Your Knowledge on Global Site Spending at the TTC - Sponsored Conference
|
| |
| PHILADELPHIA--(BUSINESS WIRE)--The ‘2nd Annual State of Clinical Development Cost Conference’ hosted by USciences and sponsored by TTC will cover a variety of detailed pharmaceutical research throughout this two day event. |
| |
| Using their industry database GrantPlan®, TTC will present total global site spending; highlighting differences by geography, type of study, and by site, as well as other factors. Subscribers to GrantPlan conduct over 76% of all commercial clinical trials worldwide. |
| |
| "the industry's single biggest opportunity for growth." |
|
| |
| In addition to the analysis on total site spending in key geographies, there will be other research topics addressed as well. These issues include how much are CROs actually used, why Latin American and Asia/Pacific investigators take part in clinical trials, the extent to which sites currently include Standard of Care considerations in the clinical trial budgeting, and which site start-up costs are part of clinical trial agreements. |
| |
|
Don’t miss the opportunity to get the most up-to-date data on these topics. If you would like to register for the conference please visit the conference website at www.stateofclindev.com or if you have any questions please email moreinfo@stateofclindev.com.
|
| |
|
Harold Glass, TTC Principal, and USciences Professor, summed up the upcoming conference as, “The‘2nd Annual State of Clinical Development Cost’ will focus on managing clinical development costs based on current industry trends, improving ROI, and increasing compliance. We are bringing together some of the best thinkers in the industry and academia for two days of notable keynote addresses, one-on-one talks, and panel discussions that covered the most up-to-date empirical research and experiences of leading edge companies.”
|
| |
|